You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 6, June 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (77)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

N-Acetyl-β-Glucosaminidase and β2-Microglobulin

Their Urinary Excretion in Patients With Renal Parenchymal Disease

Raymond L. Sherman, MD; Dennis E. Drayer, PhD; Brian R. Leyland-Jones, MB, BS; Marcus M. Reidenberg, MD

Arch Intern Med. 1983;143(6):1183-1185.


Abstract

• The urinary excretion of N-acetyl-β-glucosaminidase (NAG) and β2-microglobulin (β2M) was studied in 43 patients with various forms of renal parenchymal disease. Patients with membranous nephropathy, membranoproliferative glomerulonephritis, focal segmental glomerulosclerosis, obstructive pyelonephritis, nephrosclerosis, and minimal change nephropathy generally had urinary NAG and β2M levels more than 3 SDs above those seen in normal subjects. Patients with progressive renal disease averaged higher NAG and β2M urinary levels than those with the same renal lesion and stable function. Since elevated urinary levels of NAG and β2M suggest renal tubular injury or dysfunction, our observations suggest tubulointerstitial involvement in a wide variety of renal diseases.

(Arch Intern Med 1983;143:1183-1185)



Author Affiliations

From the Departments of Medicine (Drs Sherman, Leyland-Jones, and Reidenberg) and Pharmacology (Drs Drayer and Reidenberg), Cornell University Medical College, New York.


Footnotes

Accepted for publication Feb 4, 1983.

Reprint requests to Department of Medicine, Cornell University Medical College, New York, NY 10021 (Dr Sherman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Urine proteomics: the present and future of measuring urinary protein components in disease
Barratt and Topham
CMAJ 2007;177:361-368.
ABSTRACT | FULL TEXT  

Nitric oxide activity in childhood hypertension
Goonasekera et al.
Arch. Dis. Child. 1997;77:11-16.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.